Cooley LLP announced today that it represented BioMarin Pharmaceuticals Inc. in its acquisition of Zacharon Pharmaceuticals, a private biotechnology company based in San Diego. Under the terms of the agreement, BioMarin paid $10 million upfront for 100 percent of Zacharon’s share capital with the potential to make additional payments.

The Cooley team was led by mergers & acquisitions partner Jennifer Fonner DiNucci and included partners Marya PostnerRenee Deming and Natasha Leskovsek; senior counsels Lois Voelz and Buff Miller; and associates Dan EspinozaRobin BennettEric ChowLaura McDaniels and Michael Baker.

BioMarin announced the transaction here.


Related Posts:

Leave a Reply